Bioprodex, Inc.

Gainesville, FL

UEI
M8UKPD1A46G3
CAGE
4U6N8
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Manufacturer of Goods
  • Subcontinent Asian (Asian-Indian) American Owned
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
8520 NW 2 Pl, Gainesville, FL 32607, USA
Website
bioprodex.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Bioprodex, Inc., a minority-owned biotechnology manufacturer based in Gainesville, Florida, develops and field-tests fungal bioherbicides and biocontrol agents for federal agricultural pest management as a prime recipient of cooperative agreements from the U.S. Department of Agriculture. The company is a Subchapter S corporation and Subcontinent Asian American-owned for-profit entity that operates exclusively as a grant recipient rather than a federal contractor; all nine awards in the source data are cooperative agreements funded by USDA agencies.

Bioprodex's recent federal grant footprint centers on biological control solutions for invasive plant species and regulated agricultural pests. The department's Animal and Plant Health Inspection Service (APHIS) has funded Bioprodex across four consecutive cooperative agreements under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025) to conduct field testing and gather registration data for Verticillium nonalfalfae, a host-specific native fungal pathogen designed as a bioherbicide to control Ailanthus altissima (tree-of-heaven), an invasive weed species that serves as a primary host for the spotted lanternfly, a regulated agricultural pest. Representative awards include a $602,652 cooperative agreement (May 2022–October 2023) to gather bioherbicide registration data, a $414,782 agreement (May 2024–April 2025) continuing registration data collection, and a $307,551 agreement (June 2026–May 2027) for continued field testing and formulation development. A second USDA grant, awarded by APHIS's Central Program Planning Coordination and Support, addresses citrus huanglongbing control using a citrus isolate of Nectarine marafivirus. Bioprodex has also received awards from the USDA Forest Service R9-Eastern Region and the National Institute of Food and Agriculture.

The Department of Agriculture accounts for all nine recent awards, with APHIS dominating the footprint. Combined dollars obligated across all awards total $2.4 million. Activity is sparse and steady — one award per year from 2022 through 2026 — with two awards reaching completion inside the next twenty-four months and therefore entering recompete windows. Bioprodex operates without federal contract work or subcontractor arrangements; the vendor's federal footprint is entirely grant-recipient-based, concentrated in USDA-funded biological control and invasive species management research.

SBA capabilities narrative

BioProdex, Inc. does research and development of biological pesticides, register such pesticides with the U.S. EPA, and sell to the public to control specific pest problems. The company's focus is on biological control of invasive pest species.

Quick answers

Is Bioprodex, Inc. registered in SAM.gov?

Yes. Bioprodex, Inc.'s SAM.gov registration is active through July 19, 2027.

What is Bioprodex, Inc.'s most recent federal award?

Bioprodex, Inc.'s most recent federal grant award is The primary purpose of this agreement is to reduce the population density of the invasive weed ailanthus altissima… (AP26PPQST00C097), from Animal and Plant Health Inspection Service, on June 1, 2026.

On GovTribe

See Bioprodex, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors